Literature DB >> 20700653

Recent advances in nanotechnology based drug delivery to the brain.

Li-Na Lin1, Qun Liu, Lei Song, Fang-Fang Liu, Jin-Xiu Sha.   

Abstract

Drug delivery into the brain was difficult due to the existence of blood brain barrier, which only permits some molecules to pass through freely. In past decades, nanotechnology has enabled many technical advances including drug delivery into the brain with high efficiency and accuracy. In the present paper, we summarize recent important advances in employing nanotechnology for drug delivery to the brain as well as controlled drug release.

Year:  2010        PMID： 20700653      PMCID： PMC2993862          DOI： 10.1007/s10616-010-9295-8

Source DB:  PubMed          Journal:  Cytotechnology        ISSN： 0920-9069            Impact factor:   2.058


  32 in total

1.  Effect of chitosan on epithelial cell tight junctions.

Authors:  Jennifer Smith; Edward Wood; Michael Dornish
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

Review 2.  Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier.

Authors:  Gabriel A Silva
Journal:  Surg Neurol       Date:  2007-02

3.  Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision.

Authors:  Rutledge G Ellis-Behnke; Yu-Xiang Liang; Si-Wei You; David K C Tay; Shuguang Zhang; Kwok-Fai So; Gerald E Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

4.  Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.

Authors:  Xiaoling Gao; Bingxian Wu; Qizhi Zhang; Jun Chen; Jianhua Zhu; Weiwei Zhang; Zhengxin Rong; Hongzhuan Chen; Xinguo Jiang
Journal:  J Control Release       Date:  2007-06-02       Impact factor: 9.776

Review 5.  Nanoparticles for direct nose-to-brain delivery of drugs.

Authors:  Alpesh Mistry; Snjezana Stolnik; Lisbeth Illum
Journal:  Int J Pharm       Date:  2009-06-23       Impact factor: 5.875

6.  Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.

Authors:  Pilar Calvo; Bruno Gouritin; Henri Villarroya; Françoise Eclancher; Claudia Giannavola; Christophe Klein; Jean P Andreux; Patrick Couvreur
Journal:  Eur J Neurosci       Date:  2002-04       Impact factor: 3.386

7.  In vitro and in vivo study of solid lipid nanoparticles loaded with superparamagnetic iron oxide.

Authors:  Elena Peira; Pasquina Marzola; Valerio Podio; Silvio Aime; Andrea Sbarbati; Maria Rosa Gasco
Journal:  J Drug Target       Date:  2003-01       Impact factor: 5.121

8.  Translocation of inhaled ultrafine particles to the brain.

Authors:  G Oberdörster; Z Sharp; V Atudorei; A Elder; R Gelein; W Kreyling; C Cox
Journal:  Inhal Toxicol       Date:  2004-06       Impact factor: 2.724

9.  Reknitting the injured spinal cord by self-assembling peptide nanofiber scaffold.

Authors:  Jiasong Guo; Huanxing Su; Yuanshan Zeng; Yu-Xiang Liang; Wai Man Wong; Rutledge G Ellis-Behnke; Kwok-Fai So; Wutian Wu
Journal:  Nanomedicine       Date:  2007-10-26       Impact factor: 5.307

10.  Translocation of inhaled ultrafine manganese oxide particles to the central nervous system.

Authors:  Alison Elder; Robert Gelein; Vanessa Silva; Tessa Feikert; Lisa Opanashuk; Janet Carter; Russell Potter; Andrew Maynard; Yasuo Ito; Jacob Finkelstein; Günter Oberdörster
Journal:  Environ Health Perspect       Date:  2006-08       Impact factor: 9.031
View more
  6 in total

Review 1.  Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis.

Authors:  Morteza Mahmoudi; Mohammad A Sahraian; Mohammad A Shokrgozar; Sophie Laurent
Journal:  ACS Chem Neurosci       Date:  2011-02-04       Impact factor: 4.418

2.  Health risk assessments of lithium titanate nanoparticles in rat liver cell model for its safe applications in nanopharmacology and nanomedicine.

Authors:  Hasan Turkez; Erdal Sönmez; Antonio Di Stefano; Yousef I Mokhtar
Journal:  Cytotechnology       Date:  2014-08-23       Impact factor: 2.058

3.  Evaluation of poly(amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy.

Authors:  Magdalena Markowicz; Paweł Szymański; Marcin Ciszewski; Arkadiusz Kłys; Elżbieta Mikiciuk-Olasik
Journal:  J Biol Phys       Date:  2012-08-16       Impact factor: 1.365

4.  The use of borneol as an enhancer for targeting aprotinin-conjugated PEG-PLGA nanoparticles to the brain.

Authors:  Lin Zhang; Limei Han; Jing Qin; Weiyue Lu; Jianxin Wang
Journal:  Pharm Res       Date:  2013-04-25       Impact factor: 4.200

5.  Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.

Authors:  Ajay Vikram Singh; Manish Khare; W N Gade; Paolo Zamboni
Journal:  Autoimmune Dis       Date:  2012-12-30

6.  Apoptosis of Hepatocellular Carcinoma Cells Induced by Nanoencapsulated Polysaccharides Extracted from Antrodia Camphorata.

Authors:  Jenq-Sheng Chang; Hsiang-Ping Kuo; Ke Liang B Chang; Zwe-Ling Kong
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.